TP53 and neoplasm: To assess antitumour effects, serum lactate dehydrogenase (LDH) levels, tumour volumes, Ki‐67 and proliferating cell nuclear antigen (PCNA) immunohistochemical (IHC), and P53 immunofluorescence (IF) analysis in tumour tissues were recorded.